New Management Changes to Enhance Bartec’s Global Operations
Marcus Eisenhuth and Heiko Laubheimer

Fuel for thought

New Management Changes to Enhance Bartec’s Global Operations

08 Feb, 2016

Published over 10 years ago. See the latest and most current information on Fuel for thought.

Dr. Ralf Köster, long-time CEO of the Bartec Group (Germany), recently handed over the reins after twelve years at the head of the Bartec Group. The new management duo of Marcus Eisenhuth and Heiko Laubheimer has set itself the goal of making Bartec even more effective and visible.

Together, the new management team would like to further advance the internationally-operating safety technology provider to the status of a global player that dominates each one of its markets and every offered application. In doing so, Bartec will remain the reliable partner which clients in all segments have come to count on. In order to continue to meet the claim of very high client focus, however, service is to be improved continuously, and an even more extensive product range with all relevant certifications are to be offered around the world. Moreover, system capabilities like consultation and engineering will increasingly become the center of interest to continue simplifying product use. “Our mission is to do everything to protect people, the environment and the assets of our customers,” emphasise the two Co-CEOs. “We are looking forward to taking the necessary steps together to allow Bartec to operate more effectively on the market.”

Latest News

PIN 27.3 June/July 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Labmate Online
SERS bismuth nanoparticles sensor can spot lead ions in water at high sensitivity
Explore more Arrow
Envirotech Online
FM approval strengthens intelligent fixed gas detection for refineries and petrochemical plants
Explore more Arrow
Pollution Solutions Online
Slurry grant a fossil fuel failure?
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow